Search Results for "Breast Pap Test Trial"

05:22 EDT 29th March 2015 | BioPortfolio

Matching Channels

Sniff test

Schilling test

Spirometry Test

The gold standard in lung testing In the same way that blood pressure measurements provide a simple yet effective screening method for cardiovascular disease, spirometry tests can help to unmask t...

Breast Lumps

OncoDEEP

At OncoDNA, our philosophy is to provide the most suitable test in terms of rapidity and cost. That’s why we follow a 3 tier approach to find tumour mutations which can respond to new cancer t...

Matching News

Blood Test for Breast Cancer

It may be possible to develop a simple blood test that, by detecting changes in the zinc in our bodies, could help to diagnose breast cancer early. A team, led by Oxford University scientists, took te...

New Test Predicts Which Early Breast Cancer Will Metastasize

A test that predicts breast cancer metastases may not be too far away. Unlike other panels, this test checks for the three-cell structure found at sites of extravasation. Medscape Medical News

CASI Starts China Arm of Phase II Breast Cancer Trial

CASI Pharma, a US biopharma with strong China connections, has begun a China Phase II trial of its lead molecule, ENMD-2076, in triple-negative breast cancer. The trial is a China arm of an on-going P...

Zinc Test Could Help Diagnose Breast Cancer Early

A team, led by Oxford University scientists, took techniques normally used to analyze trace metal isotopes for studying climate change and planetary formation and applied them to how the human body pr...

Gene Test May Help Predict Return of Early Breast Tumor, Study Says

FRIDAY, Dec. 12, 2014 -- For women who have early breast tumors surgically removed, a new genetic test may help predict the odds of a recurrence, a new study says. The research, presented Friday at th...

Breast Cancer Vaccine Shows Promise in Early Trial

TUESDAY, Dec. 2, 2014 -- An experimental vaccine designed to stop breast cancer in its tracks appeared to be safe in a preliminary trial. Fourteen women with breast cancer that had spread were injecte...

Breast cancer recurrence gene test gets NHS go-ahead

A genetic test to estimate the chance of breast cancer recurrence after surgery is set to become more widely available on the NHS....

Comment: Tamoxifen lowered breast cancer rates among high-risk women

Dr Arteaga speaks to ecancertv at SABCS 2014 about the results of the International Breast Cancer Intervention Study-I (IBIS-1) trial. The trial found that tamoxifen significantly decreased the inci...

Matching PubMed Articles

Evidence for biological effects of metformin in operable breast cancer: biomarker analysis in a pre-operative window of opportunity randomized trial.

Metformin has therapeutic potential against breast cancer, but the mechanisms of action in vivo remain uncertain. This study examined biomarker effects of metformin in primary breast cancer in a preop...

Contralateral Prophylactic Mastectomy in the American College of Radiology Imaging Network 6667 Trial: Effect of Breast MR Imaging Assessments and Patient Characteristics.

Purpose To assess which patient and magnetic resonance (MR) imaging factors are associated with the likelihood of contralateral prophylactic mastectomy (CPM) in patients with newly diagnosed breast ca...

Minimal impact of adjuvant exemestane or tamoxifen treatment on mammographic breast density in postmenopausal breast cancer patients: A Dutch TEAM trial analysis.

Background. Mammographic breast density is one of the strongest independent risk factors for developing breast cancer. We examined the effect of exemestane and tamoxifen on breast density in Dutch pos...

Text-message reminders increase uptake of routine breast screening appointments: a randomised controlled trial in a hard-to-reach population.

Background:There is a need for interventions to promote uptake of breast screening throughout Europe.Methods:We performed a single-blind randomised controlled trial to test whether text-message remind...

Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial.

For most older women with early breast cancer, standard treatment after breast-conserving surgery is adjuvant whole-breast radiotherapy and adjuvant endocrine treatment. We aimed to assess the effect ...

Search Whole site using Google

Loading
Search BioPortfolio:
Loading
Advertisement
Advertisement
Advertisement Advertisement